Roberta Scherer, PhD
- Senior Scientist
- Division: Clinical Trials and Evidence Synthesis
615 N. Wolfe Street
Baltimore, Maryland 21205
PhD, Johns Hopkins School of Medicine, 1987
MS, George Washington University, 1970
As a clinical trial methodologist, my research interests include clinical trial methodology, biases associated with publication of randomized controlled trials, registration of trials at inception, and representation of trial participants by age, sex, and race. I have been involved in the design and conduct of multi- and single-centered randomized controlled trials in vision, women’s health, tinnitus, Alzheimer's disease, and complementary and alternative medicine. My interests also include the assessment of clinical trial methodology and reporting standards. I am also actively involved in the Cochrane Collaboration, an international organization that seeks to provide the basis for evidence-based medicine by collecting and synthesizing the best available evidence in the health care field, as Associate Director of the US Cochrane Center, and the Cochrane Eyes and Vision Review Group.
- Epidemiology, Cochrane Collaboration, randomized controlled trial, trial methodology
Crocetti M, Amin DD, Scherer R. Assessment of risk of bias among pediatric randomized controlled trials.Pediatrics. Published online July 12, 2010. DOI: 10.1542/peds.2009-3121.
Mishra S, Scherer RW, Aziz NM, Gotay CC, Baquet CR, Berlanstein DR, Geigle PM. Exercise interventions on health related quality of life for people with cancer during active treatment. (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No.: CD008465. DOI: 10.1002/14651858.CD008465.
Vedula S, Bero L, Scherer R, Dickersin K. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. New England Journal of Medicine. 2009 361:1963-71.
Scherer R. Evidence-based healthcare and the Cochrane Collaboration. In: Proceedings of the First International Forum towards Evidence-based Healthcare. Human & Experimental Toxicology. 2009; 28:109-11.